Objective-Infantile hemangiomas (IHs) are the most common benign vascular neoplasms of infancy, characterized by a rapid growth phase followed by a spontaneous involution, or triggered by propranolol treatment by poorly understood mechanisms. LIN28/let-7 axis plays a central role in the regulation of stem cell self-renewal and tumorigenesis. However, the role of LIN28B/let-7 signaling in IH pathogenesis has not yet been elucidated. Approach and Results-LIN28B is highly expressed in proliferative IH and is less expressed in involuted and in propranololtreated IH samples as measured by immunofluorescence staining and quantitative RT-PCR. Small RNA sequencing analysis of IH samples revealed a decrease in microRNAs that target LIN28B, including let-7, and an increase in microRNAs in the mir-498(46) cistron. Overexpression of LIN28B in HEK293 cells induced the expression of miR-516b in the mir-498(46) cistron. Propranolol treatment of induced pluripotent stem cells, which express mir-498(46) endogenously, reduced the expression of both and increased the expression of let-7. Furthermore, propranolol treatment reduced the proliferation of induced pluripotent stem cells and induced epithelial-mesenchymal transition. Conclusions-This work uncovers the role of the LIN28B/let-7 switch in IH pathogenesis and provides a novel mechanism by which propranolol induces IH involution. Furthermore, it provides therapeutic implications for cancers in which the LIN28/let-7 pathway is imbalanced. Visual Overview-An online visual overview is available for this article. 
I
nfantile hemangiomas (IHs) are highly vascularized benign tumors diagnosed in 3% to 10% of children before they are 1 year old. 1 IH lesions have a unique pattern of growth in which the initial phase of rapid proliferation is followed by slow spontaneous involution that leaves behind a fibro-fatty residuum. 2 During the proliferative phase, immature endothelial cells, positive for GLUT1 (glucose transporter-1), form aberrant blood vessels, rich in α-smooth muscle actin-positive pericytes and mast cells. 3 This endothelial GLUT1 expression distinguishes IH from other types of vascular tumors and vascular malformations. 4, 5 Stem cell reprogramming factors OCT4 (octamer-binding transcription factor 4; also known as POU5F1), SOX2 (SRY-box 2), NANOG (Nanog homeobox), and MYC (MYC proto-oncogene bHLH transcription factor) are also highly expressed in IH. 6 The chromosome 19 microRNA (miRNA) cluster (C19MC), here referred to as miRNA cistronor (precursor) cluster-mir-498 (46) , was recently reported to be highly expressed in IH. 7 Mir-498(46) is unique to primates and is the largest known human miRNA gene cluster that spans over 100 kb and contains 46 miRNA genes flanked by Alu elements. 8 Expression of miRNA genes in this cluster is restricted to the placenta, embryonic stem cell (ESC), and certain tumors. [8] [9] [10] [11] Although some studies have shown considerable similarity between IH and placental transcriptomes, 12 which suggests a placental origin for proliferating cells in IH, 13 other studies propose that IH originate from hemangioma stem cells (HemSCs). 14 In support of the latter notion, human CD133 + HemSCs implanted subcutaneously into immunodeficient mice induce GLUT1-positive microvessels, which are gradually replaced by adipocytes, thereby reproducing the IH involution phase. Importantly, when grown in culture, GLUT1-positive/mir-498(46)-expressing endothelial cells, isolated from proliferative IH, lose the expression of mir-498 (46) and GLUT1 and undergo an endothelial-mesenchymal transition, a process similar to epithelial-mesenchymal transition (EMT). 7, 15 IH represents a unique model to study postnatal vasculogenesis and vessel regression. Despite the prevalence of these tumors, the complex pathogenesis of IH is poorly understood. Given the role of LIN28/let-7 axis in governing stem cell self-renewal and cell differentiation, we hypothesized that LIN28/let-7 signaling is dysregulated in IH. In this study, we demonstrate that LIN28B is highly expressed in proliferative IH samples and is downregulated both in involuted and propranolol-treated IH samples. Consistent with those observations, in vitro treatment of iPSCs with propranolol caused a decrease in LIN28B, mir-498(46) expression, decreased cell proliferation, and increased the expression of let-7 family of miRNAs and EMT genes. Our results highlight the role of LIN28 and let-7 in the pathogenesis of IH and offer a new mechanism by which propranolol induces involution of IH.
Materials and Methods
The authors declare that all supporting data are available within the article and in the online-only Data Supplement.
Tissue Specimens
Institutional review board approval for collection of resected human hemangiomas was obtained from Columbia University College of Physicians and Surgeons (Institutional Review Board No. AAAA9976). The clinical characteristics of the patients used for this study are shown in Table I in the online-only Data Supplement. Term placental tissues from normotensive patients who were delivered by cesarean section were obtained from Tampa General Hospital/University of South Florida (Institutional Review Board No. 00015578). Written informed consent was obtained from all patients. Deidentified foreskin was used as normal infant skin (NS) and obtained from Tampa General Hospital, Tampa, FL.
Cell Culture
The human iPSC line SCVI274 was a gift from Dr Joseph C. Wu at Stanford Cardiovascular Institute, Stanford University School of Medicine. iPSCs were cultured on Matrigel-coated 6-well plates and maintained in Essential 8 medium (A1517001; Life Technologies) and passaged every fourth day. HEK293 cells (Life Technologies) were maintained in DMEM supplemented with 10% heat-inactivated fetal bovine serum (Sigma-Aldrich). Propranolol (Sigma-Aldrich, P0884) was reconstituted in dimethyl sulfoxide and used at 50 μmol/L concentration for all experiments. The HemSC line H42 was a gift from Dr June Wu at the Department of Surgery, Columbia University College of Physicians and Surgeons. In brief, freshly dissected IH tissues were digested in 0.2% collagenase A (Roche Diagnostics, Indianapolis, IN). Suspension of single cells was selected using anti-CD133-coated magnetic beads (Miltenyi Biotec) and cultured on fibronectin-coated (1 μg/cm 2 ) plates with endothelial growth media-2 SingleQuot (CC-3156; Cambrex) supplemented with 20% fetal bovine serum. 27, 28 HemSCs were maintained in EBM-2 SingleQuot media supplemented with 20% fetal bovine serum.
Transient Transfection
For LIN28B overexpression experiments, 10 5 HEK293 cells per milliliter were seeded in 12-well plates (Greiner Bio). The following day, the cells were transfected with pcDNA3-FLAG-Lin28B, a gift from Narry Kim (Addgene plasmid No. 51373) using Lipofectamine 2000 (Life Technologies) according to the manufacturer's instructions. The culture medium was changed 24 hours after transfection, and total RNA was harvested at 72 hours.
Cell Proliferation
iPSCs were grown in 6-well plates and split 1:10 at 3-day intervals. Cells were seeded at subconfluency on a Matrigel-coated 96-well plate in Essential 8 media then treated with 50 μmol/L propranolol or vehicle control for 72 hours. WST1 (tetrazolium salt) proliferation assays were performed as previously described.
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Cell Viability
The viability of iPSCs after propranolol treatment was analyzed by staining of live and dead cells with calcein acetoxymethyl and propidium iodide, respectively, 72 hours after treatment. 
RNA Isolation, Reverse Transcription Polymerase Chain Reaction, and Quantitative Polymerase Chain Reaction
Total RNA was isolated from human tissues and cultured cells using an miRNeasy Mini Kit (Qiagen) and stored at −80°C in RNAse-free water. For reverse transcription polymerase chain reaction (RT-PCR) analysis, 1 µg total RNA was reverse transcribed using random hexamer or oligodT primers and reverse transcriptase form Moloney murine leukemia virus (New England Biolabs) according to the manufacturer's specifications. For transcription assessments, cDNA products were amplified for 25 PCR cycles using previously described P0, P1, P5, P8, and P9 primer sets 30 and Q5 High Fidelity DNA polymerase (New England Biolabs). PCR products were run on 1% agarose gels and imaged with a BioDoc-It imaging system (UVP). All primers used in this study were obtained from Sigma-Aldrich. To assess relative mRNA and miRNA expression levels, quantitative RT-PCR (qRT-PCR) of cDNA products was performed using the following ThermoFisher TaqMan qRT-PCR probes: LIN28A (Hs00702808_s1), LIN28B (Hs01013729_m1), SERPINE1 (Hs00167155_m1), TWIST1 (Hs01675818_s1), GAPDH (Hs02786624_g1) miR-515-5p (001112), miR-516a-5p (002416), miR516b (001150), miR-517a (002402), miR-518c (002401), miR-519d (002403), let-7a (000377), let-7c (000379), and U18 (001204). TaqMan probes were used according to the manufacturer's instructions with TaqMan Fast Advanced Master Mix and QuantStudio 3 instrument (Life Technologies) as previously described. 31 Data were analyzed by the ΔΔC t method: target C t values and were normalized to GAPDH C t values.
DNA Isolation and HpaII Sensitivity Assay
DNA was isolated from cultured cells using the Blood and Tissue Kit (Qiagen) and stored at −20°C in RNAse-free water. Three hundred nanograms of DNA was digested with 2 µL of 10 000 U/mL HpaII (New England BioLabs) restriction enzyme or water (mock) for 12 hours. qPCR was performed using 60 ng of DNA from mock or HpaII reactions with primers designed to amplify 340 bp region containing 6 HpaII restriction sites in the mir-498(46) upstream CpG island (F: 5′-GCGCCGGCTGCACGTCCCTTAGGAG and R: 5′-CCCGCTGCCTGGAAGTATCGCCACC) and SYBR Green (SYBR Green PCR Master mix; Bio-Rad) in a QuantStudio 3 instrument (Applied Biosystems). HpaII sensitivity was calculated using the formula [1−2 Ct(mock)−Ct(HpaII) ]×100% as described. . Confocal images were obtained using an Olympus FV 1200 instrument. Immunofluorescence intensities were measured using ImageJ software as described. 33 Fluorescence intensities were normalized to background intensities of secondary antibody-only controls.
Immunoblotting
Immunoblot analyses were performed as previously described 34 using 24 ng/mL antibodies against GAPDH (Cell Signaling Technology Cat No. 2118L RRID:AB_561053) and 0.2 µg/µL antibodies against LIN28B (Abcam Cat No. ab71415 RRID:AB_2135050) followed by IRDye 680 donkey anti-rabbit IGG secondary antibodies (0.2 μg/ mL, LI-COR, 926-68073 RRID:AB_10954442). Immunoblots were imaged using the Odyssey Infrared Imaging System (LI-COR) and quantified using Image Studio software (LI-COR).
miRNA and mRNA Sequencing
Two micrograms of total RNA was converted into a small RNA cDNA library according to the previously published protocol. 35 In brief, the RNA input for each sample was ligated to a 3′ adapter barcoded sequence, pooled, size selected, and gel purified, followed by 5′ adapter ligation and then subjected to size selection and gel purification. The cDNA library preparation was completed by second-strand synthesis using SuperScript III, alkaline RNA hydrolysis, and PCR amplification for 10 cycles. mRNA libraries were prepared using the Illumina TruSeq Stranded mRNA LT protocol using 500 ng total RNA as input according to the manufacturer's protocol but substituting New England BioLabs Protoscript II reverse transriptase for the first-strand cDNA synthesis. Individual RNAseq libraries were quality controlled on an Agilent TapeStation with a High Sensitivity D1000 ScreenTape. Indexed samples were quantified using the Qubit dsDNA HS assay and pooled at equimolar concentration (10 nmol/L). The libraries were sequenced on an Illumina NextSeq 500 sequencer 75-bp paired-end in mid output mode in the Genomics Core Facility of The Rockefeller University.
Bioinformatics Analysis
The miRNA read annotation for small RNA sequencing (sRNAseq) experiments was performed as previously described 36,37 using a slightly updated, manually curated miRNA reference based on previous work. 38 Nomenclature of single miRNAs and definition and nomenclature of miRNA cistrons (or precursor clusters) are given in Figure I in the online-only Data Supplement of Akat et al. 39 The RNAseq data were aligned to the Human Genome Build 38 using the STAR aligner 40 (version 2.0.4j) allowing for 2 mismatches. Expression values (count matrices) were generated using featureCounts against gene definitions from Ensembl release 88 (Gene Transfer Format file) using fractional counting of multi-mapping reads.
Statistical Analysis
sRNAseq and RNAseq data analyses were performed using the R statistical language. Differential analysis was performed using the Bioconductor package edgeR. All RT-PCR and immunoblotting data are reported as mean±SEM. All data were tested for normality. Comparisons between 2 groups of normally distributed data were made by 2-tailed Student t tests with correction for unequal variance, whereas comparisons of data that were not normally distributed were done using Mann-Whitney U tests. Comparisons with >2 groups were subject to one-way ANOVA with Dunnett post hoc tests against controls. Statistical testing was performed with IBM SPSS 24. P <0.05 was considered statistically significant or as specified in the relevant tables and figure legends.
Results
LIN28B Is Highly Expressed in Proliferative IH and Is Reduced on Involution
IHs are derived from dysregulated stem cells 41 and represent a unique tumor model characterized by a proliferative phase followed by spontaneous involution, regulated by yet unknown mechanisms. Given the key role of the LIN28/let-7 axis in governing stem cell self-renewal and cell differentiation, the expression levels of LIN28A and LIN28B were first assessed in IH samples by qRT-PCR and compared with NS and samples of normal human placentas at term. IH samples exhibited a 7-and 7500-fold increase (P<0.05) in LIN28A and LIN28B, respectively, compared with NS ( Figure 1A ). The expression levels of LIN28A and LIN28B in IH were comparable to their expression levels in the placenta ( Figure 1A) . Given the dramatic increase of LIN28B expression in IH, all subsequent experiments were focused on LIN28B. To determine if LIN28B is differentially expressed in proliferative IH compared with involuting/involuted IH, we assessed LIN28B expression by qRT-PCR and found that it was 2.7-fold higher (P<0.33) in proliferative compared with involuting/involuted IH samples ( Figure 1B) .
To determine LIN28B cellular localization, dual immunofluorescence staining for LIN28B and the IH marker, GLUT1, was performed in paraffin-embedded IH sections obtained from proliferative and involuted IH specimens. Term placenta samples were used as positive controls. In proliferative IH samples, LIN28B was highly expressed and colocalized with the GLUT1-positive endothelial cells and perivascular nonendothelial cells, whereas involuted IH samples showed weak staining for both LIN28B and GLUT1 ( Figure 1C) . In term placentas, LIN28B and GLUT1 were colocalized in tropoblast and endothelium of chorionic villi, as expected ( Figure 1C) . Quantifications of LIN28B to GLUT1 immunofluorescence signal intensities showed ≈2-fold increase in proliferative IH Highly expressed cistrons were defined as being within the top 90% RNAseq reads in any of the 8 infantile hemangiomas (IH) and 5 normal skin (NS) samples. Shown are cistrons with a false discovery rate (FDR) of <25% in the differential analysis.
compared with involuted IH samples ( Figure 1D ). These data confirm the increased expression of LIN28B in proliferative IH and its localization in GLUT1-positive endothelial cells and perivascular nonendothelial cells that may display properties of facultative stem cells. 15 The let-7 miRNA family and numerous other miRNAs negatively regulate LIN28B by binding to its 3′ UTR ( Figure 1E ). To determine whether the increase in LIN28B in IH samples is associated with decreased expression of these miRNAs, sRNAseq analysis was performed on 8 IHs and 5 NS samples. Looking at the most abundant, or highly expressed, miRNAs (ie, consuming the top 90% of sequencing reads) in IH compared with NS samples showed 32 significantly changed miRNA cistrons (FDR=0.25), of which 21 were upregulated in IH and 11 downregulated in IH compared with NS (Table 1) . Of the 21 upregulated miRNA cistrons, mir-498(46) was most extensively upregulated with a 492-fold increase ( Table 1 ). The downregulated cistrons include miRNAs that are predicted to bind to LIN28B 3′ UTR, namely let-7a, let-7c, let-7f, let-7g, let-7i, miR-19b(2), miR-506(1), miR-196a/b, miR-455-5p(1), miR-9(3), miR-124(3), miR-27a(1), miR-27b(1), miR-23b(1), miR-125b(2), miR-199b-5p(1), miR-19a(1), and miR-148a(1), which were 2-to 45.6-fold downregulated (Table II in the online-only Data Supplement). Importantly, let-7, miR-196, and miR-9 bind to multiple target sites on LIN28B 3′ UTR ( Figure 1E ). These data indicate that the upregulation of LIN28B in IH may be due, at least in part, to its decreased posttranscriptional regulation by miRNAs. In addition, LIN28B is an established repressor of miRNA biogenesis, 42 among which let-7 is the most extensively studied. 43 Consequently, sRNAseq analysis of IH and NS revealed that let-7g(1), let-7c(1), and miR-200c(1) were 2.9-, 3.6-and 135-fold downregulated, respectively, in IH compared with NS (Table II in the onlineonly Data Supplement). To determine whether additional members of the let-7 family were affected, yet did not pass the sRNAseq analysis filters, qRT-PCR analysis was performed for randomly selected members let-7a and let-7c. As expected, both were downregulated (P<0.05) in IH compared with NS ( Figure 1F ).
LIN28B Activates mir-498(46) miRNAs Independently of the Upstream CpG Island
The expression of mir-498(46) is controlled by methylation of an upstream CpG-rich promoter region that includes a transcription start site located ≈17 kb upstream of the first miRNA gene. 30 To test whether the increase in mir-498(46) expression found in IH samples is because of transcriptional activation of the upstream CpG-rich island, we performed qRT-PCR using primer sets designed to amplify regions downstream of the CpG island, as previously described. 30 The trophoblastderived choriocarcinoma BeWo cell line, which endogenously expresses mir-498(46), was used as a positive control. IH samples and BeWo cells displayed active transcription starting at the ≈17 kb upstream mir-498(46) CpG-related promoter region, whereas no transcripts were found in NS samples (Figure 2A ). This indicates that the promoter region upstream of mir-498(46) is transcriptionally active in IH.
Given that LIN28B expression is 7000-fold higher in IH than NS, we tested for a possible positive regulation of mir-498(46) miRNAs by LIN28B. To that end, HEK293 cells were transiently transfected with a LIN28B-coding plasmid, and the expression levels of LIN28B and of 6 randomly selected miRNAs of mir-498(46) miRNAs were measured after 72 hours by immunoblotting and qRT-PCR, respectively. Interestingly, overexpression of LIN28B enhanced the expression of miR516b by >2.6-fold (P<0.05) but did not significantly alter the expression of miR-515-5p, miR-516a-5p, miR-517a, miR518c, and miR-519d ( Figure 2B ).
To test whether LIN28B affects the methylation of the ≈17 kb CpG island upstream of mir-498(46) which activates its transcription, we performed an HpaII sensitivity assay followed by qPCR. Overexpression of LIN28B did not induce a significant increase in HpaII sensitivity of the CpG island ( Figure 2C) or induce transcriptional activation downstream of the CpG island ( Figure 2D ). These data indicate that LIN28B induces the expression of mir-498(46) independently of the ≈17 kb upstream promoter region.
Propranolol Inhibits LIN28B in IH and iPSC
The standard of care propranolol treatment of patients with IH induces rapid IH involution. To determine whether propranolol affects the expression of LIN28B in IH, we performed dual immunofluorescence staining of LIN28B and the IH marker, GLUT1, in paraffin-embedded IH sections obtained from propranolol-treated proliferative IH and compared them to untreated proliferative IH samples. Both LIN28B and GLUT1 were markedly decreased in propranolol-treated proliferative IH compared with untreated proliferative IH ( Figure 3A) . In addition, quantification of LIN28B to GLUT1 immunofluorescence signal intensities showed ≈2-fold increase in proliferative IH compared with propranolol-treated IH samples ( Figure 3B ).
To further investigate the effects of propranolol on the expression of LIN28B and let-7 in IH, we used the CD133 + HemSCs, which form hemangioma-like tumors when injected subcutaneously in immunodeficient mice.
14 First, we tested whether HemSCs express LIN28B and the miR-498(46) cluster in NS and IH. We also tested their expression in BeWo cells and iPSCs, which are known to express high levels of both. As negative controls, we used human umbilical vein endothelial cells (HUVECs) that express neither LIN28B nor miR-498 (46) . Surprisingly, qRT-PCR revealed that compared with NS, LIN28B showed only a 2-fold increase in HemSCs, whereas in IH, iPSCs and BeWo cells LIN28B was >1000-fold (P<0.05) higher ( Figure 3C ). As expected, negligible LIN28B expression was found in HUVECs ( Figure 3C) . Moreover, sRNAseq analysis revealed that miR-498(46) expression levels were 3.1-, 4.1-, 28-, and 492.7-fold higher in HemSCs, HUVECs, iPSCs, and IH, respectively, compared with NS (Table II in the online-only Data Supplement). Last, the expression of LIN28B protein in HemSC and iPSCs was also assessed by Western blot analysis, which showed negligible levels of LIN28B in HemSCs ( Figure 3D ). On the basis of these findings, we proceeded to test the effect of propranolol in iPSCs, that express LIN28B, miR498 (46) , and β-adrenergic receptors. After propranolol treatment for 72 hours, iPSCs showed a 2.3-fold decrease (P<0.05) in LIN28B protein levels ( Figure 3E ), but no significant differences were found at the mRNA levels (data not shown).
Propranolol Induces mir-98(13) and Suppresses mir-498(46) in iPSCs
To further investigate the effects of propranolol on the expression of mir-498(46) and let-7, iPSCs were treated with propranolol for 72 hours and sRNAseq analysis was performed. Compared with vehicle control, propranolol-treated iPSCs showed a 3.2-fold increase in the expression of cistron mir-98(13), which encodes 9 of 12 let-7 family miRNA genes, and a 1.6-fold downregulation of mir-498(46) ( Table 2) . The results were confirmed by qRT-PCR, which revealed significant reduction of mir-498(46) members miR-515-5p, miR517a, miR-518c, and miR-519d, and a 1.65-fold increase in let-7a expression in propranolol treated iPSCs ( Figure 4A ).
Propranolol Induces EMT Markers in iPSC
Propranolol has been shown to induce early involution of IH, during which immature vascular endothelial cells undergo endothelial-mesenchymal transition, transitioning to a mesenchymal phenotype with subsequent differentiation into adipocytes. 15 To test whether propranolol induces the expression of mesenchymal markers, we performed mRNA sequencing (RNAseq) on the same propranolol-and vehicle-treated iPSC samples that were used for sRNAseq. Gene set enrichment analysis performed on RNAseq data showed an enrichment of genes defining EMT, (FDR=0.00046) in propranolol-treated iPS cells compared with control (Table III in the online-only Data Supplement). Gene set analysis also showed upregulation of the pathways for adipogenesis and TGF (transforming growth factor)-β signaling (FDR=0.09 and 0.06 respectively; Table III in the online-only Data Supplement). Among the most highly upregulated genes, 2 mesenchymal cell markers, SERPINE1 (Serpin family E member 1) and TWIST1, showed a 12-and 2.9-fold increase (FDR=1.06×10 −6 and 0.004), respectively (Table III in the online-only Data Supplement). Upregulation of SERPINE1 and TWIST1 was further confirmed by qRT-PCR, which showed 8.4-and 5-fold increased expression (P<0.05), respectively ( Figure 4B ). Furthermore, gene set analysis of the RNAseq data also showed downregulation of E2F transcription factor family targets, G2 phase/ mitosis cell cycle checkpoint, and mitotic spindle pathways (FDR<0.25; Table III in the online-only Data Supplement). We also examined propranolol-treated iPSCs for EMT-associated morphological changes and observed that propranolol-treated iPSCs exhibited a more elongated cellular shape compared with control ( Figure 4C and 4D ). Next, we tested the effect of propranolol on iPSC proliferation using the WST1 proliferation assay. Propranolol treatment induced a 33% decrease in cell proliferation without affecting cell viability ( Figure 4E and  4F) . Furthermore, gene set enrichment analysis also showed that E2F target genes and genes involved in G2/M cell cycle progression are downregulated by propranolol treatment in iPSCs (FDR=0.006 and 0.017, respectively; Table III in the online-only Data Supplement) indicating that propranolol strongly inhibits proliferation. 
Discussion
IH is a unique tumor model, characterized by a rapid proliferative phase followed by a spontaneous or propranolol-induced involution phase. The mechanisms that trigger spontaneous involution and the action of propranolol are still under investigation. The present study shows that the reprogramming factor LIN28B is highly expressed in the proliferative IH phase but is significantly decreased in involuted IH and in IH tissues from propranolol-treated patients. The high LIN28B expression in proliferative IH correlates with the expression of the ESCenriched mir-498(46) [44] [45] [46] and is inversely correlated with the expression of let-7 miRNAs. Treatment of iPSCs with propranolol reduced the expression of LIN28B and mir-498 (46) and induced the expression of let-7 family of miRNAs and EMT genes. Moreover, propranolol treatment reduced iPSC cell proliferation.
The increase in LIN28B and reduction in let-7 reported in this study highlight the role of stem cells in the pathology of IH. Although HemSCs, which are 0.2% of the proliferative hemangioma cell population, are believed to be the cellular origin of IH, our data show that these cells do not express LIN28B and miR-498(46) in tissue culture. 14, 15 However, our in vivo data show that LIN28B is localized in GLUT1-positive endothelial cells that were previously characterized as stem cell like. 15 These cells formed colonies that could be induced to redifferentiate into endothelial cells, pericytes/smooth muscle cells, or adipocytes. Interestingly, when these GLUT1-positive endothelial cells were cultured for 3 weeks, they converted to a mesenchymal phenotype and lost GLUT1 and mir-498(46) expression. 7, 15 It would be of interest to test whether freshly isolated HemSCs express LIN28B and mir-498(46) or implantation of HemSC into immunodeficient mice restores LIN28B and mir-498(46) expression. Nevertheless, increased expression of stem cell transcription factors OCT4, SOX2, NANOG, and MYC has been reported in IH. 6 In addition, our in vivo data also show that in proliferative IH LIN28 was not limited to GLUT1-positive cells but was also expressed in perivascular nonendothelial cells, which are essential for the maintenance of IH vessels stability. 47 The increase in LIN28B in IH reported here may be because of transcriptional and post-transcriptional activation. The reprogramming transcription factors such as MYC has been shown to transactivate LIN28B. 48, 49 Although little is known about the transcriptional activation of LIN28B, post-transcriptional regulation by miRNAs such as let-7 and other miRNAs has been extensively studied. 23, 50 Furthermore, LIN28B was reported to bind its own mRNA, increasing its stability and protein abundance. 51 Thus, our sRNAseq results are in line with previous reports and highlight the central role of the LIN28B/let-7 switch in governing stem cell self-renewal in the proliferative phase of IH.
We also showed that the ESC-enriched miRNA cluster mir-498(46) is highly expressed in IH. This cluster of miRNAs is normally imprinted, with only the paternally inherited allele expressed in the placenta. 30 The overexpression of mir-498(46) seen in IH could be regulated by methylation of the upstream CpG island or by chromosomal rearrangements such as amplifications of the corresponding chromosome 19 region, as found in embryonal tumor with multilayered rosettes, 16 primitive neuroectodermal tumors, and in thyroid adenomas. 11, 52, 53 Given the ability of IH to undergo spontaneous involution, the elevated expression of mir-498(46) in proliferative IH is unlikely to be because of DNA amplifications or translocations, but rather, because of epigenetic modification. We therefore proceeded to investigate the previously identified promoter region and transcription start site that overlap an annotated CpG island located ≈17 kb upstream of the first miRNA gene of mir-498 (46) . Although our findings show that, unlike NS, IH samples exhibited active transcription starting from the upstream CpG island, similar to that seen in the placenta, 30 they do not preclude the existence of additional active promoter regions within mir-498 (46) . In fact, mir-498(46) carries numerous CpG dinucleotide islands extensively interspersed with Alu-rich repeats, which account for over 50% of the 100-kb sequence. Numerous studies showed that Alu methylation is highly dynamic and Alu-rich regions can function as independent promoters for RNA polymerase II and RNA polymerase III in both mesenchymal stem cells and cancer stem cells. 44, 54, 55 Although LIN28 is a well-established inhibitor of miRNA maturation, 18, 42, 51, 56 the present study revealed that overexpression of LIN28B increased the expression of miR-516b of mir-498 (46) . This is especially noteworthy given that LIN28B can be used along with other reprogramming factors to generate pluripotent stem cells enriched with mir-498 (46) . In fact, a recent study showed that LIN28A activates gene expression by binding directly to a consensus DNA sequence at promoter regions and recruiting the CpG demethylase TET1 (Tet methylcytosine dioxygenase 1). 57 Previous study showed that both mesenchymal stem and cancer stem cells exhibit disperse expression patterns of miRNAs of the mir-498(46) cluster rather than a bloc expression regulated by the upstream promoter. 44 Accordingly, our data show that overexpression of LIN28B did not affect the methylation of the upstream CpG island or increase the transcription in that region indicating the existence of downstream promoter regions. LIN28B may bind to the Alu repeats within mir-498 (46) , which may function as independent RNA polymerase II promoters and activate transcription by recruiting TET1. In fact, analyses of previously published PAR-CLIP (photoactivatable ribonucleosideenhanced crosslinking and immunoprecipitation) data show that LIN28B binds numerous Alu repeats located in the mir-498 (46) . 51 This unexpected result points to a potential binding of LIN28B to the CpG-rich Alu repeats to activate transcription. Moreover, LIN28 is a potent RNA-binding protein that regulates splicing factor abundance 58 and, therefore, may induce processing of the transcript of mir-498(46) cistron.
In the last decade, propranolol has become the preferred treatment for morbid proliferating IH. To date, >500 published articles describe the observed propranolol-induced involution of IH and the various hypotheses on its mechanisms of action. Here, we propose a new model through which propranolol triggers rapid IH involution. We demonstrate that propranolol induces a shift in LIN28B/let-7 balance to favor cell differentiation and senescence. This model is based on the data presented here, which show that propranolol reduced the expression of LIN28B and increased the expression of let-7 in IH samples in vivo and in iPSCs in vitro. Furthermore, we show that propranolol reduces the proliferation of iPSCs and initiates the conversion to mesenchymal phenotype as evidenced by the increase in SERPINE1 and TWIST1 expression, while reducing the expression of miRNAs of the mir-498(46) cistron. RNAseq and gene set analyses confirmed the downregulation in E2F targets, G2M checkpoint, and mitotic spindle pathways and showed upregulation in EMT, adipogenesis, and TGF-β signaling pathways. To our knowledge, this is the first report to show that propranolol reduces the proliferation of iPSCs and induces EMT and adipogenesis. These profound effects of propranolol may be due in part to the reduction in LIN28B that binds and regulates mRNAs of cell cycle regulators 51 and as a consequence of the increase in let-7 miRNAs, which regulate Rb1/E2F genes. 59 The induction of EMT genes by propranolol is in agreement with a previous study that showed that activation of adenylyl cyclase and elevation in cAMP and EPAC (exchange factor directly activated by cAMP) signaling replaced the need for OCT4 for iPSC generation. This cAMP-dependent reprogramming increased cellular division rate and induced genes involved in mesenchymal-epithelial transition. 60 Therefore, by reducing cAMP levels, propranolol may be inducing EMT and thus accelerating IH involution. Of note, propranolol has been shown to induce adipogenesis in HemSCs. 61, 62 Last, the reduction in miRNAs of the mir-498(46) cistron in propranolol-treated iPSCs reported here is in agreement with previous work that showed that propranolol-treated IH tissues contained significantly lower levels of mir-498(46) miRNAs than did proliferative, untreated IH. 7 The LIN28/let-7 axis is implicated not only in pluripotency but also in tumorigenesis, especially in cancer stem cells, which are resistant to chemotherapies and promote metastasis. 50, 63 In fact, numerous preclinical and clinical studies provide evidence that propranolol increases chemosensitivity and reduces the metastatic rates in multiple cancer types. 64 The present work highlights the role of the LIN28B/ let-7 switch in IH pathogenesis and propranolol-induced IH involution. This study may also have therapeutic implications for IH and for cancers in which the LIN28/let-7 pathway is imbalanced.
